Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
NAING, AUNG
One or more keywords matched the following items that are connected to NAING, AUNG
Item TypeName
Academic Article Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
Academic Article Biomarkers of response to immune checkpoint blockade in cancer treatment.
Academic Article Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment.
Concept B7-H1 Antigen
Academic Article Exposure to anti-PD-1 causes functional differences in tumor-infiltrating lymphocytes in rare solid tumors.
Academic Article Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology.
Academic Article Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors.
Academic Article PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
Academic Article The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
Academic Article Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial.
Academic Article Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial.
Academic Article Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with?non-small cell lung cancer.
Academic Article Baseline extracellular vesicle TGF-? is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer.
Academic Article Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.
Academic Article Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC.
Search Criteria
  • B7 2 Antigen